FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3047060676> ?p ?o ?g. }

• W3047060676 endingPage "1246" @default.
• W3047060676 startingPage "1246" @default.
• W3047060676 abstract "Antidepressants are commonly used during pregnancy, but limited information is available about individual antidepressants and specific birth defect risks.To examine associations between individual antidepressants and specific birth defects with and without attempts to partially account for potential confounding by underlying conditions.The population-based, multicenter case-control National Birth Defects Prevention Study (October 1997-December 2011) included cases with selected birth defects who were identified from surveillance systems; controls were randomly sampled live-born infants without major birth defects. Mothers of cases and controls participated in an interview after the expected delivery date. The data were analyzed after the completion of the National Birth Defects Prevent Study's data collection.Self-reported antidepressant exposure was coded to indicate monotherapy exposure to antidepressants.We used multivariable logistic regression to calculate adjusted odds ratios (aORs) and 95% confidence intervals for associations between maternal antidepressant use and birth defects. We compared early pregnancy antidepressant-exposed women with those without antidepressant exposure and, to partially account for confounding by underlying maternal conditions, those exposed to antidepressants outside of the birth defect development critical period.This study included 30 630 case mothers of infants with birth defects and 11 478 control mothers (aged 12-53 years). Early pregnancy antidepressant use was reported by 1562 case mothers (5.1%) and 467 control mothers (4.1%), for whom elevated aORs were observed for individual selective serotonin reuptake inhibitors (SSRIs) and selected congenital heart defects (CHD) (eg, fluoxetine and anomalous pulmonary venous return: aOR, 2.56; 95% CI, 1.10-5.93; this association was attenuated after partially accounting for underlying conditions: aOR, 1.89; 95% CI, 0.56-6.42). This pattern was observed for many SSRI-CHD combinations. Associations between SSRIs and non-CHD birth defects often persisted or strengthened after partially accounting for underlying conditions (eg, citalopram and diaphragmatic hernia: aOR, 5.11; 95% CI, 1.29-20.24). Venlafaxine had elevated associations with multiple defects that persisted after partially accounting for underlying conditions (eg, anencephaly and craniorachischisis: aOR, 9.14; 95% CI, 1.91-43.83).We found some associations between maternal antidepressant use and specific birth defects. Venlafaxine was associated with the highest number of defects, which needs confirmation given the limited literature on venlafaxine use during pregnancy and risk for birth defects. Our results suggest confounding by underlying conditions should be considered when assessing risk. Fully informed treatment decision-making requires balancing the risks and benefits of proposed interventions against those of untreated depression or anxiety." @default.
• W3047060676 created "2020-08-10" @default.
• W3047060676 creator A5020501305 @default.
• W3047060676 creator A5022750141 @default.
• W3047060676 creator A5030628980 @default.
• W3047060676 creator A5034428800 @default.
• W3047060676 creator A5042954847 @default.
• W3047060676 creator A5047486011 @default.
• W3047060676 creator A5051342376 @default.
• W3047060676 creator A5055104036 @default.
• W3047060676 date "2020-12-01" @default.
• W3047060676 modified "2023-10-13" @default.
• W3047060676 title "Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects" @default.
• W3047060676 cites W1807564164 @default.
• W3047060676 cites W1849790101 @default.
• W3047060676 cites W1866814291 @default.
• W3047060676 cites W1897763284 @default.
• W3047060676 cites W1908254154 @default.
• W3047060676 cites W1930136637 @default.
• W3047060676 cites W1966526645 @default.
• W3047060676 cites W1971008606 @default.
• W3047060676 cites W1975558262 @default.
• W3047060676 cites W1978332054 @default.
• W3047060676 cites W1978522713 @default.
• W3047060676 cites W1981640001 @default.
• W3047060676 cites W2032387823 @default.
• W3047060676 cites W2042263278 @default.
• W3047060676 cites W2061286725 @default.
• W3047060676 cites W2062240933 @default.
• W3047060676 cites W2063638540 @default.
• W3047060676 cites W2078684918 @default.
• W3047060676 cites W2092861046 @default.
• W3047060676 cites W2094051697 @default.
• W3047060676 cites W2105840567 @default.
• W3047060676 cites W2114602840 @default.
• W3047060676 cites W2127147289 @default.
• W3047060676 cites W2144256602 @default.
• W3047060676 cites W2144278613 @default.
• W3047060676 cites W2149154629 @default.
• W3047060676 cites W2153712846 @default.
• W3047060676 cites W2160473344 @default.
• W3047060676 cites W2177099710 @default.
• W3047060676 cites W2251990316 @default.
• W3047060676 cites W2267691753 @default.
• W3047060676 cites W2282746037 @default.
• W3047060676 cites W2345643776 @default.
• W3047060676 cites W2414392164 @default.
• W3047060676 cites W2558819716 @default.
• W3047060676 cites W2576556180 @default.
• W3047060676 cites W2622412817 @default.
• W3047060676 cites W2889273255 @default.
• W3047060676 cites W2899847685 @default.
• W3047060676 cites W2909608103 @default.
• W3047060676 cites W2921495327 @default.
• W3047060676 cites W2922853138 @default.
• W3047060676 cites W2955859765 @default.
• W3047060676 cites W4230197589 @default.
• W3047060676 cites W4234907873 @default.
• W3047060676 cites W4238590367 @default.
• W3047060676 cites W4239237548 @default.
• W3047060676 cites W4240822226 @default.
• W3047060676 cites W4243606275 @default.
• W3047060676 cites W4251124349 @default.
• W3047060676 cites W4253513759 @default.
• W3047060676 cites W4254349977 @default.
• W3047060676 cites W4256401320 @default.
• W3047060676 cites W4297900878 @default.
• W3047060676 doi "https://doi.org/10.1001/jamapsychiatry.2020.2453" @default.
• W3047060676 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7407327" @default.
• W3047060676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32777011" @default.
• W3047060676 hasPublicationYear "2020" @default.
• W3047060676 type Work @default.
• W3047060676 sameAs 3047060676 @default.
• W3047060676 citedByCount "48" @default.
• W3047060676 countsByYear W30470606762020 @default.
• W3047060676 countsByYear W30470606762021 @default.
• W3047060676 countsByYear W30470606762022 @default.
• W3047060676 countsByYear W30470606762023 @default.
• W3047060676 crossrefType "journal-article" @default.
• W3047060676 hasAuthorship W3047060676A5020501305 @default.
• W3047060676 hasAuthorship W3047060676A5022750141 @default.
• W3047060676 hasAuthorship W3047060676A5030628980 @default.
• W3047060676 hasAuthorship W3047060676A5034428800 @default.
• W3047060676 hasAuthorship W3047060676A5042954847 @default.
• W3047060676 hasAuthorship W3047060676A5047486011 @default.
• W3047060676 hasAuthorship W3047060676A5051342376 @default.
• W3047060676 hasAuthorship W3047060676A5055104036 @default.
• W3047060676 hasBestOaLocation W30470606761 @default.
• W3047060676 hasConcept C118552586 @default.
• W3047060676 hasConcept C126322002 @default.
• W3047060676 hasConcept C131872663 @default.
• W3047060676 hasConcept C146304588 @default.
• W3047060676 hasConcept C156957248 @default.
• W3047060676 hasConcept C170493617 @default.
• W3047060676 hasConcept C187212893 @default.
• W3047060676 hasConcept C2775864247 @default.
• W3047060676 hasConcept C2776134451 @default.
• W3047060676 hasConcept C2777669559 @default.

• next